Business Description
Inovio Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US45773H4092
Description
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.81 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -23.83 | |||||
| Beneish M-Score | -1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -59.5 | |||||
| 3-Year EBITDA Growth Rate | 20.2 | |||||
| 3-Year EPS without NRI Growth Rate | 7.7 | |||||
| 3-Year FCF Growth Rate | 26 | |||||
| 3-Year Book Growth Rate | -44.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 28.95 | |||||
| Future 3-5Y Total Revenue Growth Rate | 290.85 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.86 | |||||
| 9-Day RSI | 12.27 | |||||
| 14-Day RSI | 11.9 | |||||
| 6-1 Month Momentum % | -48.13 | |||||
| 12-1 Month Momentum % | -45.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.88 | |||||
| Quick Ratio | 3.88 | |||||
| Cash Ratio | 3.61 | |||||
| Days Sales Outstanding | 10.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.5 | |||||
| Shareholder Yield % | -15.94 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -58540.69 | |||||
| Net Margin % | -55331.37 | |||||
| FCF Margin % | -55247.99 | |||||
| ROE % | -108.49 | |||||
| ROA % | -76.89 | |||||
| ROIC % | -334.38 | |||||
| ROC (Joel Greenblatt) % | -811.67 | |||||
| ROCE % | -97.85 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 214.44 | |||||
| PB Ratio | 0.68 | |||||
| Price-to-Tangible-Book | 0.68 | |||||
| EV-to-EBIT | 0.02 | |||||
| EV-to-EBITDA | 0.02 | |||||
| EV-to-Revenue | -13.17 | |||||
| EV-to-Forward-Revenue | 201.96 | |||||
| EV-to-FCF | 0.02 | |||||
| Price-to-Median-PS-Value | 6.43 | |||||
| Price-to-Net-Current-Asset-Value | 0.87 | |||||
| Price-to-Net-Cash | 0.98 | |||||
| Earnings Yield (Greenblatt) % | 5000 | |||||
| FCF Yield % | -159.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inovio Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 3.609 | ||
| EPS (TTM) (MXN) | -79.629 | ||
| Beta | 1.04 | ||
| Volatility % | 110.75 | ||
| 14-Day RSI | 11.9 | ||
| 14-Day ATR (MXN) | 1.946419 | ||
| 20-Day SMA (MXN) | 54.571 | ||
| 12-1 Month Momentum % | -45.75 | ||
| 52-Week Range (MXN) | 39 - 235 | ||
| Shares Outstanding (Mil) | 36.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inovio Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inovio Pharmaceuticals Inc Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inovio Pharmaceuticals Inc Frequently Asked Questions
What is Inovio Pharmaceuticals Inc(MEX:INO)'s stock price today?
The current price of MEX:INO is MXN40.00. The 52 week high of MEX:INO is MXN235.00 and 52 week low is MXN39.00.
When is next earnings date of Inovio Pharmaceuticals Inc(MEX:INO)?
The next earnings date of Inovio Pharmaceuticals Inc(MEX:INO) is 2025-03-06 Est..
Does Inovio Pharmaceuticals Inc(MEX:INO) pay dividends? If so, how much?
Inovio Pharmaceuticals Inc(MEX:INO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers